Inhibition of DT-diaphorase (NAD(P)H:Quinone oxidoreductase, ec 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development-Reference-Cited by-同舟云学术

Inhibition of DT-diaphorase (NAD(P)H:Quinone oxidoreductase, ec 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development

Published:1999-07 Issue:2 Volume:58 Page:303-310
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Phillips Roger M

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. Bioreductive drugs for cancer therapy;Adams;Int J Radiat Oncol Biol Phys,1994

2. Reduction of tumour blood flow by flavone acetic acid;Bibby;J Natl Cancer Inst,1989

3. Correlation between immune and vascular activities of xanthenone acetic acid antitumour agents;Zwi;Oncol Res,1994

4. Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid;Laws;Br J Cancer,1995

5. Enhancement of the antitumour effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma;Sun;Cancer Res,1989

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulated Ca2+ signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjögren’s disease;eLife;2024-09-11

2. Dysregulated Ca2+ signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjögren’s disease;eLife;2024-09-11

3. Dysregulated Ca2+ signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjögren’s syndrome;2024-08-22

4. A caged metabolic precursor for DT-diaphorase-responsive cell labeling;Chemical Communications;2018

5. Synthesis and in vitro evaluation of radioiodinated indolequinones targeting NAD(P)H: Quinone oxidoreductase 1 for internal radiation therapy;Bioorganic & Medicinal Chemistry;2014-11